Sort
34,240 grants matching “atherosclerosis”
Lipids, Inflammation and Insulin Action
$380,711Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2011 · DK
The role of PON-2 and PON3 proteins in atherosclerosis
$380,692Srinivasa Reddy · University Of California Los Angeles · R01 · FY2009 · HL
The role of PON-2 and PON3 proteins in atherosclerosis
$380,692Srinivasa Reddy · University Of California Los Angeles · R01 · FY2010 · HL
The role of PON-2 and PON3 proteins in atherosclerosis
$380,692Srinivasa Reddy · University Of California Los Angeles · R01 · FY2008 · HL
The role of PON-2 and PON3 proteins in atherosclerosis
$380,692Srinivasa Reddy · University Of California Los Angeles · R01 · FY2007 · HL
New Pathway Limits Cellular Cholesterol Content
$380,686University Of California San Francisco · R01 · FY2001 · HL
Juvenile Protective Factor Deficits in Endothelial Aging, Dysfunction and Disease
$380,656Victoria L Herrera · Boston University Medical Campus · R01 · FY2008 · AG
Juvenile Protective Factor Deficits in Endothelial Aging, Dysfunction and Disease
$380,656Victoria L Herrera · Boston University Medical Campus · R01 · FY2009 · AG
Depression, Epinephrine, Serotonin, &Platelet Function
$380,636Emory University · R01 · FY2005 · HL
Iron Therapy in Renal Disease: Potential Toxicities
$380,600Fred Hutchinson Cancer Research Center · R01 · FY2004 · DK
Iron Therapy in Renal Disease: Potential Toxicities
$380,600Fred Hutchinson Cancer Research Center · R01 · FY2005 · DK
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation
$380,587Nhat-Tu Le · Methodist Hospital Research Institute · R01 · FY2020 · HL
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation
$380,587Nhat-Tu Le · Methodist Hospital Research Institute · R01 · FY2019 · HL
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formation
$380,587Nhat-Tu Le · Methodist Hospital Research Institute · R01 · FY2021 · HL
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin
$380,539Steven Shea · Columbia University Health Sciences · N01 · FY2021 · HL
Gene-by-Smoking Interaction and Risk of Atherosclerosis
$380,538University Of North Carolina Chapel Hill · R01 · FY2003 · HL
Dynamic Interplay of Eicosanoids in Atherosclerosis
$380,532Garret A Fitzgerald · University Of Pennsylvania · P01 · FY2006 · HL
RNA-binding proteins in atherosclerosis
$380,529Tamer Sallam · University Of California Los Angeles · R01 · FY2021 · HL
p120 Catenin and Endothelial Monolayer Function
$380,500Peter A Vincent · Albany Medical College · R01 · FY2006 · HL
Maintaining Mitochondrial Health into Old Age
$380,498Shane Rea · University Of Washington · R01 · FY2020 · AG
RNA-binding proteins in atherosclerosis
$380,491Tamer Sallam · University Of California Los Angeles · R01 · FY2018 · HL
Mechanisms in CD36 Signal Transduction
$380,490Massachusetts General Hospital · R01 · FY2003 · AG
Mechanisms in CD36 Signal Transduction
$380,490Massachusetts General Hospital · R01 · FY2004 · AG
Cardiovascular and Renal Protection with SGLT2 Inhibition in Kidney Transplant Recipients (RENAISSANCE)
$380,466Arthur J Matas · University Of Minnesota · U34 · FY2025 · DK
LFA-1 in lymphocyte migration
$380,456Minsoo Kim · University Of Rochester · R01 · FY2015 · HL